Back
JPMorgan BetaBuilders US Mid Cap Eq ETF Vs. Avidity Biosciences Industry Stock Comparison
Buy
73
BBMC
JPMorgan BetaBuilders US Mid Cap Eq ETF
Last Price:
101.23
Seasonality Move:
8.21%
Sell
28
RNA
Avidity Biosciences
Last Price:
42.16
Seasonality Move:
39.98%
Buy
73
JPMorgan BetaBuilders US Mid Cap Eq ETF (BBMC)
is a Buy
Is JPMorgan BetaBuilders US Mid Cap Eq ETF a Buy, Sell or Hold?
- The current JPMorgan BetaBuilders US Mid Cap Eq ETF [BBMC] share price is $98.96. The Score for BBMC is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- BBMC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BBMC Stock Price Chart
What is JPMorgan BetaBuilders US Mid Cap Eq ETF's stock price today?
-
The JPMorgan BetaBuilders US Mid Cap Eq ETF share price today is $98.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBMC is experiencing slight selling pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $42.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
BBMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.65 | Buy |
| Relative Strength Index (14 RSI): | 57.14 | Buy |
| Chaikin Money Flow: | -2133 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (94.61 - 99.77) | Buy |
| Bollinger Bands (100): | (88.71 - 96.23) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 42.17 | Sell |
| Chaikin Money Flow: | -1839481 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.78 - 48.76) | Sell |
| Bollinger Bands (100): | (41.56 - 46.96) | Sell |
BBMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 100.71 | Sell |
| 20-day SMA: | 97.35 | Buy |
| 50-day SMA: | 95.13 | Buy |
| 200-day SMA: | 90.43 | Buy |
| 8-day EMA: | 99.72 | Sell |
| 20-day EMA: | 98.1 | Buy |
| 50-day EMA: | 95.67 | Buy |
| 200-day EMA: | 90.23 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.51 | Sell |
| 20-day SMA: | 45.87 | Sell |
| 50-day SMA: | 45.1 | Sell |
| 200-day SMA: | 34.2 | Buy |
| 8-day EMA: | 46.84 | Sell |
| 20-day EMA: | 46.32 | Sell |
| 50-day EMA: | 45.24 | Sell |
| 200-day EMA: | 35.58 | Buy |
JPMorgan BetaBuilders US Mid Cap Eq ETF Earnings Growth & BBMC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.25 per share.
JPMorgan BetaBuilders US Mid Cap Eq ETF Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||